|
|||||
|
|
DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind,Placebo‐Controlled Study |
|
| Authors: | Richard B. Lipton MD Sagar Munjal MD MS Elimor Brand‐Schieber PhD Alan M. Rapoport MD |
| Affiliation: | 1. Montefiore Medical Center, Bronx, NY, USA;2. Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA;3. Promius Pharmaa subsidiary of Dr. Reddy's Laboratories, Princeton, NJ, USA;4. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA |
| Abstract: | |
| Keywords: | migraine acute treatment sumatriptan intranasal permeation enhancer |